<?xml version="1.0" encoding="UTF-8"?>
<ref id="B56-antibiotics-10-00092">
 <label>56.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Le</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Kunold</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Macsics</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Rox</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Jennings</surname>
    <given-names>M.C.</given-names>
   </name>
   <name>
    <surname>Ugur</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Reinecke</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Chaves-Moreno</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Hackl</surname>
    <given-names>M.W.</given-names>
   </name>
   <name>
    <surname>Fetzer</surname>
    <given-names>C.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Repurposing human kinase inhibitors to create an antibiotic active against drug-resistant 
   <italic>Staphylococcus aureus</italic>, persisters and biofilms
  </article-title>
  <source>Nat. Chem.</source>
  <year>2020</year>
  <volume>12</volume>
  <fpage>145</fpage>
  <lpage>158</lpage>
  <pub-id pub-id-type="doi">10.1038/s41557-019-0378-7</pub-id>
  <pub-id pub-id-type="pmid">31844194</pub-id>
 </element-citation>
</ref>
